fda compounding semaglutide enforcement 2025 news Compound versions of GLP-1 drugs for weight loss halted by August 11, 2025: The FDA
Description
The SWFLA To Do List has events listed far in advance of those in print, so that you can plan ahead
Preparation of key intermediates
Reconstitution and storage considerations Compounded GLP-1 peptides require proper reconstitution and storage, and errors in either process could affect the drug's molecular integrity
In the full episode, Nick Allan and Nigel Syrotuck compare different GLP-1 drugs and unpack how those molecular differences translate into real-world dosing and device design
Do you know the differences between the three main development strategies in GLP-1 clinical trials
